Evidence map›Paper›PMID 26965447›Full record

ArticleAmerican journal of obstetrics and gynecology2016

The placental membrane microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis.

Amanda L Prince, Jun Ma, Paranthaman S Kannan, Manuel Alvarez, Tate Gisslen, R Alan Harris, Emma L Sweeney, Christine L Knox, Donna S Lambers, Alan H Jobe and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 3 pooled it
27.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 3 syntheses or guidelines pooled it, 282 citations in OpenAlex.

  1. Pooled it
  2. [Pathways and Mechanisms of Periodontitis Contributing to Adverse Pregnancy Outcomes].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Detection ofFrontiers in cellular and infection microbiology · 2025
    Article
  16. Article
  17. Evaluation of the Human Placental Microbiota in Early- and Late-Onset Pre-Eclampsia.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2024
    Article
  18. Nutraceuticals in Pregnancy: A Special Focus on Probiotics.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Amanda L Prince *Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Jun Ma *Departments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Paranthaman S KannanDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Manuel AlvarezDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Tate GisslenDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
R Alan HarrisDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Emma L SweeneyDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Christine L KnoxDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Donna S LambersDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Alan H JobeDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Claire A ChougnetDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Suhas G KallapurDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Kjersti M AagaardDepartments of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine (Drs Prince, Ma, Harris, and Aagaard), Molecular & Human Genetics (Drs Harris and Aagaard), Molecular & Cell Biology (Dr Aagaard), and Molecular & Cellular Physiology (Dr Aagaard), Baylor College of Medicine, Houston, TX; Divisions of Neonatology (Drs Kannan, Gisslen, Jobe, and Kallapur and Mr Alvarez) and Immunology (Dr Chougnet), the Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH; Queensland University of Technology, Brisbane, QLD, Australia (Drs Sweeney and Knox); and Department of Obstetrics, Maternal-Fetal Medicine, Good Samaritan Hospital, Cincinnati, OH (Dr Lambers).
Baylor College of Medicine · USCincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · USQueensland University of Technology · AUGood Samaritan Hospital · US

Funding

Conserved Fetal Epigenomic Signatures in a Primate Model of Maternal ObesityR01DK089201 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2012 to 2021
$5.1M
A Multi'omics Approach towards Deciphering the Influence of the Microbiome on PreR01NR014792 · NINR · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2013 to 2017
$2.7M
Characterization of the Fetal Primate Epigenome and Metabolome Under In UteroDP2OD001500 · OD · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2007 to 2011
$2.3M
Late Preterm Birth, Ureaplasma Species and Childhood Lung DiseaseR01HL097064 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI JOBE, ALAN H, KALLAPUR, SUHAS · 2009 to 2012
$2.0M
Regulation of the microbiome by epigenetic programming of the immune systemF32HD082969 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI PRINCE, AMANDA · 2015 to 2017
$170k
NHLBI NIH HHS R01 HL097064NICHD NIH HHS F32 HD082969NIDDK NIH HHS R01 DK089201NIH HHS DP2 OD001500NINR NIH HHS R01 NR014792
6 · The paper itself

Abstract

backgroundPreterm birth (PTB) is a leading cause of neonatal morbidity and mortality and is not uncommonly associated with chorioamnionitis. We recently have demonstrated that the placenta harbors a unique microbiome with similar flora to the oral community. We also have shown an association of these placental microbiota with PTB, history of antenatal infection, and excess maternal weight gain. On the basis of these previous observations, we hypothesized that the placental membranes would retain a microbiome community that would vary in association with preterm birth and chorioamnionitis.

objectiveIn the current study, we aimed to examine the differences in the placental membrane microbiome in association with PTB in both the presence and absence of chorioamnionitis and/or funisitis using state-of-the-science whole-genome shotgun metagenomics. STUDY

designThis was a cross-sectional analysis with 6 nested spontaneous birth cohorts (n = 9-15 subjects/cohort): Term gestations without chorioamnionitis, term with chorioamnionitis, preterm without chorioamnionitis, preterm with mild chorioamnionitis, preterm with severe chorioamnionitis, and preterm with chorioamnionitis and funisitis. Histologic analysis was performed with Redline's criteria, and inflammatory cytokines were analyzed in the cord blood. DNA from placental membranes was extracted from sterile swabs collected at delivery, and whole-genome shotgun sequencing was performed on the Illumina HiSeq platform. Filtered microbial DNA sequences were annotated and analyzed with MG-RAST (ie, Metagenomic Rapid Annotations using Subsystems Technology) and R.

resultsSubjects were assigned to cohorts on the basis of gestational age at delivery and independent scoring of histologic chorioamnionitis. We found that preterm subjects with severe chorioamnionitis and funisitis had increases in cord blood inflammatory cytokines. Of interest, although the placental membrane microbiome was altered in association with severity of histologic chorioamnionitis (permutational multivariate analysis of variance P = .005), there was no observable impact with either betamethasone or antibiotic treatment. In preterm subjects with chorioamnionitis, we found a high abundance of both urogenital and oral commensal bacteria. These alterations in the microbiome were accompanied by significant variation (P < .05) in microbial metabolic pathways important in the glucose-fed pentose phosphate pathway (term subjects), or glycerophopholipid metabolism, and the biosynthesis of the siderophore group nonribosomal peptides (preterm subjects).

conclusionConsistent with ours and others previous findings, women who experienced spontaneous PTB harbor placental microbiota that further differed by severity of chorioamnionitis. Integrative metagenomic analysis revealed significant variation in distinct bacterial metabolic pathways, which we speculate may contribute to risk of preterm birth with and without severe chorioamnionitis.

Indexed as

MicrobiotaPremature BirthButyratesChorioamnionitisCross-Sectional StudiesDNA, BacterialFemaleGlycerophospholipidsHumansMetagenomicsPentose Phosphate PathwayPlacentaPregnancyRiboflavinSequence Analysis, DNASeverity of Illness IndexButyratesDNA, BacterialGlycerophospholipidsRiboflavinchorioamnionitisfunisitismicrobiomepreterm birthwhole-genome shotgun metagenomics

Identifiers

PMID26965447
PMCPMC4909356
OpenAlexW2293680190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.